Volume 12, Number 4—April 2006
Research
Human Trypanosoma cruzi Infection and Seropositivity in Dogs, Mexico
Jose G. Estrada-Franco*1, Vandanajay Bhatia*1, Hector Diaz-Albiter†, Laucel Ochoa-Garcia†, Alberto Barbabosa‡, Juan C. Vazquez-Chagoyan‡, Miguel A. Martinez-Perez‡, Carmen Guzman-Bracho§, and Nisha Garg*
Table 2
Prevalence of antibodies to Trypanosoma cruzi in persons in southern area of the State of Mexico*
| Municipality | Village | Altitude (m) | No. screened | Seropositivity,† no. (%) |
||
|---|---|---|---|---|---|---|
| IgG positive | IgM positive‡ | IgG and IgM positive | ||||
| Tejupilco | El Carmen Ixtapan | 1,091 | 16 | 1 (6.3) | 3 (18.7) | 4 (25.0) |
| El Puerto del Salitre | 1,268 | 29 | 3 (10.3) | ND | 3 (10.3) | |
| Zacatepec | 1,311 | 200 | 2 (1.0) | 10 (5.0) | 11 (5.5) | |
| Rio Grande | 1,554 | 3 | 0 | ND | 0 | |
| Tenería | 1,730 | 45 | 0 | 3 (6.6) | 3 (6.6) | |
| Subtotal | 293 | 6 (2.05) | 16 (5.5) | 21 (7.1) | ||
| Temascaltepec | La Cominidad | 2,500 | 63 | 0 | 1 (1.6) | 1 (1.6) |
*IgG, immunoglobulin G.
†p<0.001 for IgG, IgM, and IgG plus IgM seropositivity.
‡All IgM-seropositive persons were 4–13 y of age. ND, not determined.
1These authors contributed equally to this work.
Page created: January 23, 2012
Page updated: January 23, 2012
Page reviewed: January 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.